Supply, use, and abuse of intravenous immunoglobulin.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Current opinion in pediatrics

• Publication date

  1999-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00008480-199912000-00011PMID 10590912
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.

  1999cited by this paper
• Recurrent lymphocytic pleural effusion after intravenous immunoglobulin

  1999cited by this paper
• Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases.

  1999cited by this paper
• Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.

  1999cited by this paper
• Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients.

  1999cited by this paper
• Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.

  1999cited by this paper
• Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion.

  1999cited by this paper
• Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin.

  1999cited by this paper
• Immunoglobulin replacement treatment by rapid subcutaneous infusion

  1998cited by this paper
• Benefits of high-dose i.v. immunoglobulin in patients with severe steroid-dependent asthma.

  1998cited by this paper
• Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease

  1998cited by this paper
• Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIV

  1998cited by this paper
• Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome.

  1998cited by this paper
• Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group.

  1998cited by this paper
• Modulation of endothelial cell function by normal polyspecific human intravenous immunoglobulins: a possible mechanism of action in vascular diseases.

  1998cited by this paper
• Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants.

  1998cited by this paper
• Intravenous immunoglobulin inhibits IgE production in human B lymphocytes.

  1998cited by this paper
• Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose.

  1997cited by this paper
• Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study.

  1996cited by this paper
• Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children.

  1996cited by this paper
• Aseptic Meningitis Associated with High-Dose Intravenous Immunoglobulin Therapy: Frequency and Risk Factors

  1994cited by this paper
• A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.

  1994cited by this paper
• Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.

  1994cited by this paper
• A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

  1993cited by this paper
• Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.

  1993cited by this paper
• Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children

  1993cited by this paper
• Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection.

  1991cited by this paper
• The immunologic effects of IVIG in Kawasaki disease.

  1989cited by this paper
• The use of intravenous gamma-globulin in idiopathic thrombocytopenic purpura.

  1989cited by this paper
• The use of intravenous γ-globulin in idiopathic thrombocytopenic purpura

  1989cited by this paper
• Replacement therapy with high dose intravenous gamma‐globulin improves chronic sinopulmonary disease in patients with hypogammaglobulinemia

  1988cited by this paper
• High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease.

  1987cited by this paper
• Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA.

  1986cited by this paper
• Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.

  1982cited by this paper

• Transfusion Medicine

  2021cites this paper
• Comparative Study of Two ELISA Kits for Estimation of Antibodies to Hepatitis B Virus in Human Normal Immunoglobulin and Specific Immunoglobulin Intended for Intravenous or Intramuscular Use

  2017cites this paper
• Calidad de vida de los pacientes con inmunodeficiencias primarias de anticuerpos

  2016cites this paper
• Flebogamma® 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases

  2016cites this paper
• The role of intravenous immunoglobulins in the treatment of rheumatoid arthritis.

  2015cites this paper
• Home gammaglobulin therapy: a patient survey of intravenous and subcutaneous options in Canada

  2014cites this paper
• Use of Blood Products

  2011cites this paper
• Economic assessment of different modalities of immunoglobulin replacement therapy.

  2008cites this paper
• Economic A ssessment of Different Modalities of I mmunoglobulin Replacement Therapy

  2008cites this paper
• Efficacy and Tolerability of an Argentine Intravenous Immunoglobulin in Pediatric Patients with Primary Immunodeficiency Diseases

  2007cites this paper
• Novel mutations in the respiratory syncytial virus G gene identified in viral isolates from a girl with severe combined immune deficiency treated with intravenous immune globulin.

  2006cites this paper
• Intravenous Immunoglobulin: Striving for Appropriate Use

  2006cites this paper
• Severe dengue: coming soon to a pediatric intensive care unit near you?

  2005cites this paper
• Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders

  2004cites this paper
• The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease.

  2004cites this paper
• Vaccines in pregnancy: a review of their importance in Brazil.

  2003cites this paper
• Intravenous immunoglobulin: appropriate indications and uses in hematopoietic stem cell transplantation.

  2002cites this paper
• Developments in Component Therapy: Novel Components and New Uses for Familiar Preparations

  2002cites this paper
• Intravenous immunoglobulin: regulatory perspectives on use and supply

  2001cites this paper
• Hypogammaglobulinemia complicating chylothorax after cardiac surgery in two infants.

  2001cites this paper
• Prevention of respiratory syncytial virus infections.

  2001cites this paper
• IVIG-pools: regulatory gifts--transiting from harmony toward harmonious immunoglobulins: why? and why not?

  2001cites this paper
• Bacteremia and skin/bone infections in two patients with X-linked agammaglobulinemia caused by an unusual organism related to Flexispira/Helicobacter species.

  2000cites this paper